Global Biotechnological Enzyme Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Page: 103
Published Date: 17 May 2022
Category: Chemical & Material
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
The Biotechnological Enzyme market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biotechnological Enzyme market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Industrial Catalysts accounting for % of the Biotechnological Enzyme global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hydrolases segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Biotechnological Enzyme include Novozymes, North Carolina Biotechnology Center, Lumis Biotech, Zytex, and AB Enzymes, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biotechnological Enzyme market is split by Drug Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Drug Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Drug Type, covers
Hydrolases
Lyases
Isomerases
Ligases
Others
Market segment by Application, can be divided into
Industrial Catalysts
Therapeutic Agents
Analytic Reagents
Others
Market segment by players, this report covers
Novozymes
North Carolina Biotechnology Center
Lumis Biotech
Zytex
AB Enzymes
EPYGEN LABS LLC.
Fermenta Biotech Limited
CPC Biotech
Nfinita Biotech Private Limited
MetGen
SYNKROMAX BIOTECH PVT LTD.
Biocatalysts Ltd.
Henkel AG & Co.
KGaA
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biotechnological Enzyme product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biotechnological Enzyme, with revenue, gross margin and global market share of Biotechnological Enzyme from 2019 to 2022.
Chapter 3, the Biotechnological Enzyme competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Drug Type and application, with revenue and growth rate by Drug Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biotechnological Enzyme market forecast, by regions, drug type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biotechnological Enzyme research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Biotechnological Enzyme
1.2 Classification of Biotechnological Enzyme by Drug Type
1.2.1 Overview: Global Biotechnological Enzyme Market Size by Drug Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Biotechnological Enzyme Revenue Market Share by Drug Type in 2021
1.2.3 Hydrolases
1.2.4 Lyases
1.2.5 Isomerases
1.2.6 Ligases
1.2.7 Others
1.3 Global Biotechnological Enzyme Market by Application
1.3.1 Overview: Global Biotechnological Enzyme Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Industrial Catalysts
1.3.3 Therapeutic Agents
1.3.4 Analytic Reagents
1.3.5 Others
1.4 Global Biotechnological Enzyme Market Size & Forecast
1.5 Global Biotechnological Enzyme Market Size and Forecast by Region
1.5.1 Global Biotechnological Enzyme Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Biotechnological Enzyme Market Size by Region, (2017-2022)
1.5.3 North America Biotechnological Enzyme Market Size and Prospect (2017-2028)
1.5.4 Europe Biotechnological Enzyme Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Biotechnological Enzyme Market Size and Prospect (2017-2028)
1.5.6 South America Biotechnological Enzyme Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Biotechnological Enzyme Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biotechnological Enzyme Market Drivers
1.6.2 Biotechnological Enzyme Market Restraints
1.6.3 Biotechnological Enzyme Trends Analysis
2 Company Profiles
2.1 Novozymes
2.1.1 Novozymes Details
2.1.2 Novozymes Major Business
2.1.3 Novozymes Biotechnological Enzyme Product and Solutions
2.1.4 Novozymes Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Novozymes Recent Developments and Future Plans
2.2 North Carolina Biotechnology Center
2.2.1 North Carolina Biotechnology Center Details
2.2.2 North Carolina Biotechnology Center Major Business
2.2.3 North Carolina Biotechnology Center Biotechnological Enzyme Product and Solutions
2.2.4 North Carolina Biotechnology Center Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 North Carolina Biotechnology Center Recent Developments and Future Plans
2.3 Lumis Biotech
2.3.1 Lumis Biotech Details
2.3.2 Lumis Biotech Major Business
2.3.3 Lumis Biotech Biotechnological Enzyme Product and Solutions
2.3.4 Lumis Biotech Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Lumis Biotech Recent Developments and Future Plans
2.4 Zytex
2.4.1 Zytex Details
2.4.2 Zytex Major Business
2.4.3 Zytex Biotechnological Enzyme Product and Solutions
2.4.4 Zytex Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Zytex Recent Developments and Future Plans
2.5 AB Enzymes
2.5.1 AB Enzymes Details
2.5.2 AB Enzymes Major Business
2.5.3 AB Enzymes Biotechnological Enzyme Product and Solutions
2.5.4 AB Enzymes Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 AB Enzymes Recent Developments and Future Plans
2.6 EPYGEN LABS LLC.
2.6.1 EPYGEN LABS LLC. Details
2.6.2 EPYGEN LABS LLC. Major Business
2.6.3 EPYGEN LABS LLC. Biotechnological Enzyme Product and Solutions
2.6.4 EPYGEN LABS LLC. Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 EPYGEN LABS LLC. Recent Developments and Future Plans
2.7 Fermenta Biotech Limited
2.7.1 Fermenta Biotech Limited Details
2.7.2 Fermenta Biotech Limited Major Business
2.7.3 Fermenta Biotech Limited Biotechnological Enzyme Product and Solutions
2.7.4 Fermenta Biotech Limited Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Fermenta Biotech Limited Recent Developments and Future Plans
2.8 CPC Biotech
2.8.1 CPC Biotech Details
2.8.2 CPC Biotech Major Business
2.8.3 CPC Biotech Biotechnological Enzyme Product and Solutions
2.8.4 CPC Biotech Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 CPC Biotech Recent Developments and Future Plans
2.9 Nfinita Biotech Private Limited
2.9.1 Nfinita Biotech Private Limited Details
2.9.2 Nfinita Biotech Private Limited Major Business
2.9.3 Nfinita Biotech Private Limited Biotechnological Enzyme Product and Solutions
2.9.4 Nfinita Biotech Private Limited Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Nfinita Biotech Private Limited Recent Developments and Future Plans
2.10 MetGen
2.10.1 MetGen Details
2.10.2 MetGen Major Business
2.10.3 MetGen Biotechnological Enzyme Product and Solutions
2.10.4 MetGen Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 MetGen Recent Developments and Future Plans
2.11 SYNKROMAX BIOTECH PVT LTD.
2.11.1 SYNKROMAX BIOTECH PVT LTD. Details
2.11.2 SYNKROMAX BIOTECH PVT LTD. Major Business
2.11.3 SYNKROMAX BIOTECH PVT LTD. Biotechnological Enzyme Product and Solutions
2.11.4 SYNKROMAX BIOTECH PVT LTD. Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 SYNKROMAX BIOTECH PVT LTD. Recent Developments and Future Plans
2.12 Biocatalysts Ltd.
2.12.1 Biocatalysts Ltd. Details
2.12.2 Biocatalysts Ltd. Major Business
2.12.3 Biocatalysts Ltd. Biotechnological Enzyme Product and Solutions
2.12.4 Biocatalysts Ltd. Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Biocatalysts Ltd. Recent Developments and Future Plans
2.13 Henkel AG & Co.
2.13.1 Henkel AG & Co. Details
2.13.2 Henkel AG & Co. Major Business
2.13.3 Henkel AG & Co. Biotechnological Enzyme Product and Solutions
2.13.4 Henkel AG & Co. Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Henkel AG & Co. Recent Developments and Future Plans
2.14 KGaA
2.14.1 KGaA Details
2.14.2 KGaA Major Business
2.14.3 KGaA Biotechnological Enzyme Product and Solutions
2.14.4 KGaA Biotechnological Enzyme Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 KGaA Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biotechnological Enzyme Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Biotechnological Enzyme Players Market Share in 2021
3.2.2 Top 10 Biotechnological Enzyme Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Biotechnological Enzyme Players Head Office, Products and Services Provided
3.4 Biotechnological Enzyme Mergers & Acquisitions
3.5 Biotechnological Enzyme New Entrants and Expansion Plans
4 Market Size Segment by Drug Type
4.1 Global Biotechnological Enzyme Revenue and Market Share by Drug Type (2017-2022)
4.2 Global Biotechnological Enzyme Market Forecast by Drug Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Biotechnological Enzyme Revenue Market Share by Application (2017-2022)
5.2 Global Biotechnological Enzyme Market Forecast by Application (2023-2028)
6 North America by Country, by Drug Type, and by Application
6.1 North America Biotechnological Enzyme Revenue by Drug Type (2017-2028)
6.2 North America Biotechnological Enzyme Revenue by Application (2017-2028)
6.3 North America Biotechnological Enzyme Market Size by Country
6.3.1 North America Biotechnological Enzyme Revenue by Country (2017-2028)
6.3.2 United States Biotechnological Enzyme Market Size and Forecast (2017-2028)
6.3.3 Canada Biotechnological Enzyme Market Size and Forecast (2017-2028)
6.3.4 Mexico Biotechnological Enzyme Market Size and Forecast (2017-2028)
7 Europe by Country, by Drug Type, and by Application
7.1 Europe Biotechnological Enzyme Revenue by Drug Type (2017-2028)
7.2 Europe Biotechnological Enzyme Revenue by Application (2017-2028)
7.3 Europe Biotechnological Enzyme Market Size by Country
7.3.1 Europe Biotechnological Enzyme Revenue by Country (2017-2028)
7.3.2 Germany Biotechnological Enzyme Market Size and Forecast (2017-2028)
7.3.3 France Biotechnological Enzyme Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Biotechnological Enzyme Market Size and Forecast (2017-2028)
7.3.5 Russia Biotechnological Enzyme Market Size and Forecast (2017-2028)
7.3.6 Italy Biotechnological Enzyme Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Drug Type, and by Application
8.1 Asia-Pacific Biotechnological Enzyme Revenue by Drug Type (2017-2028)
8.2 Asia-Pacific Biotechnological Enzyme Revenue by Application (2017-2028)
8.3 Asia-Pacific Biotechnological Enzyme Market Size by Region
8.3.1 Asia-Pacific Biotechnological Enzyme Revenue by Region (2017-2028)
8.3.2 China Biotechnological Enzyme Market Size and Forecast (2017-2028)
8.3.3 Japan Biotechnological Enzyme Market Size and Forecast (2017-2028)
8.3.4 South Korea Biotechnological Enzyme Market Size and Forecast (2017-2028)
8.3.5 India Biotechnological Enzyme Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Biotechnological Enzyme Market Size and Forecast (2017-2028)
8.3.7 Australia Biotechnological Enzyme Market Size and Forecast (2017-2028)
9 South America by Country, by Drug Type, and by Application
9.1 South America Biotechnological Enzyme Revenue by Drug Type (2017-2028)
9.2 South America Biotechnological Enzyme Revenue by Application (2017-2028)
9.3 South America Biotechnological Enzyme Market Size by Country
9.3.1 South America Biotechnological Enzyme Revenue by Country (2017-2028)
9.3.2 Brazil Biotechnological Enzyme Market Size and Forecast (2017-2028)
9.3.3 Argentina Biotechnological Enzyme Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Drug Type, and by Application
10.1 Middle East & Africa Biotechnological Enzyme Revenue by Drug Type (2017-2028)
10.2 Middle East & Africa Biotechnological Enzyme Revenue by Application (2017-2028)
10.3 Middle East & Africa Biotechnological Enzyme Market Size by Country
10.3.1 Middle East & Africa Biotechnological Enzyme Revenue by Country (2017-2028)
10.3.2 Turkey Biotechnological Enzyme Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Biotechnological Enzyme Market Size and Forecast (2017-2028)
10.3.4 UAE Biotechnological Enzyme Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Biotechnological Enzyme Revenue by Drug Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Biotechnological Enzyme Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Biotechnological Enzyme Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Biotechnological Enzyme Revenue (USD Million) by Region (2017-2022)
Table 5. Global Biotechnological Enzyme Revenue Market Share by Region (2023-2028)
Table 6. Novozymes Corporate Information, Head Office, and Major Competitors
Table 7. Novozymes Major Business
Table 8. Novozymes Biotechnological Enzyme Product and Solutions
Table 9. Novozymes Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. North Carolina Biotechnology Center Corporate Information, Head Office, and Major Competitors
Table 11. North Carolina Biotechnology Center Major Business
Table 12. North Carolina Biotechnology Center Biotechnological Enzyme Product and Solutions
Table 13. North Carolina Biotechnology Center Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Lumis Biotech Corporate Information, Head Office, and Major Competitors
Table 15. Lumis Biotech Major Business
Table 16. Lumis Biotech Biotechnological Enzyme Product and Solutions
Table 17. Lumis Biotech Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Zytex Corporate Information, Head Office, and Major Competitors
Table 19. Zytex Major Business
Table 20. Zytex Biotechnological Enzyme Product and Solutions
Table 21. Zytex Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. AB Enzymes Corporate Information, Head Office, and Major Competitors
Table 23. AB Enzymes Major Business
Table 24. AB Enzymes Biotechnological Enzyme Product and Solutions
Table 25. AB Enzymes Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. EPYGEN LABS LLC. Corporate Information, Head Office, and Major Competitors
Table 27. EPYGEN LABS LLC. Major Business
Table 28. EPYGEN LABS LLC. Biotechnological Enzyme Product and Solutions
Table 29. EPYGEN LABS LLC. Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Fermenta Biotech Limited Corporate Information, Head Office, and Major Competitors
Table 31. Fermenta Biotech Limited Major Business
Table 32. Fermenta Biotech Limited Biotechnological Enzyme Product and Solutions
Table 33. Fermenta Biotech Limited Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. CPC Biotech Corporate Information, Head Office, and Major Competitors
Table 35. CPC Biotech Major Business
Table 36. CPC Biotech Biotechnological Enzyme Product and Solutions
Table 37. CPC Biotech Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Nfinita Biotech Private Limited Corporate Information, Head Office, and Major Competitors
Table 39. Nfinita Biotech Private Limited Major Business
Table 40. Nfinita Biotech Private Limited Biotechnological Enzyme Product and Solutions
Table 41. Nfinita Biotech Private Limited Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. MetGen Corporate Information, Head Office, and Major Competitors
Table 43. MetGen Major Business
Table 44. MetGen Biotechnological Enzyme Product and Solutions
Table 45. MetGen Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. SYNKROMAX BIOTECH PVT LTD. Corporate Information, Head Office, and Major Competitors
Table 47. SYNKROMAX BIOTECH PVT LTD. Major Business
Table 48. SYNKROMAX BIOTECH PVT LTD. Biotechnological Enzyme Product and Solutions
Table 49. SYNKROMAX BIOTECH PVT LTD. Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Biocatalysts Ltd. Corporate Information, Head Office, and Major Competitors
Table 51. Biocatalysts Ltd. Major Business
Table 52. Biocatalysts Ltd. Biotechnological Enzyme Product and Solutions
Table 53. Biocatalysts Ltd. Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Henkel AG & Co. Corporate Information, Head Office, and Major Competitors
Table 55. Henkel AG & Co. Major Business
Table 56. Henkel AG & Co. Biotechnological Enzyme Product and Solutions
Table 57. Henkel AG & Co. Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. KGaA Corporate Information, Head Office, and Major Competitors
Table 59. KGaA Major Business
Table 60. KGaA Biotechnological Enzyme Product and Solutions
Table 61. KGaA Biotechnological Enzyme Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Biotechnological Enzyme Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Biotechnological Enzyme Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Biotechnological Enzyme by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Biotechnological Enzyme Players Head Office, Products and Services Provided
Table 66. Biotechnological Enzyme Mergers & Acquisitions in the Past Five Years
Table 67. Biotechnological Enzyme New Entrants and Expansion Plans
Table 68. Global Biotechnological Enzyme Revenue (USD Million) by Drug Type (2017-2022)
Table 69. Global Biotechnological Enzyme Revenue Share by Drug Type (2017-2022)
Table 70. Global Biotechnological Enzyme Revenue Forecast by Drug Type (2023-2028)
Table 71. Global Biotechnological Enzyme Revenue by Application (2017-2022)
Table 72. Global Biotechnological Enzyme Revenue Forecast by Application (2023-2028)
Table 73. North America Biotechnological Enzyme Revenue by Drug Type (2017-2022) & (USD Million)
Table 74. North America Biotechnological Enzyme Revenue by Drug Type (2023-2028) & (USD Million)
Table 75. North America Biotechnological Enzyme Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Biotechnological Enzyme Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Biotechnological Enzyme Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Biotechnological Enzyme Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Biotechnological Enzyme Revenue by Drug Type (2017-2022) & (USD Million)
Table 80. Europe Biotechnological Enzyme Revenue by Drug Type (2023-2028) & (USD Million)
Table 81. Europe Biotechnological Enzyme Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Biotechnological Enzyme Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Biotechnological Enzyme Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Biotechnological Enzyme Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Biotechnological Enzyme Revenue by Drug Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Biotechnological Enzyme Revenue by Drug Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Biotechnological Enzyme Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Biotechnological Enzyme Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Biotechnological Enzyme Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Biotechnological Enzyme Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Biotechnological Enzyme Revenue by Drug Type (2017-2022) & (USD Million)
Table 92. South America Biotechnological Enzyme Revenue by Drug Type (2023-2028) & (USD Million)
Table 93. South America Biotechnological Enzyme Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Biotechnological Enzyme Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Biotechnological Enzyme Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Biotechnological Enzyme Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Biotechnological Enzyme Revenue by Drug Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Biotechnological Enzyme Revenue by Drug Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Biotechnological Enzyme Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Biotechnological Enzyme Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Biotechnological Enzyme Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Biotechnological Enzyme Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Biotechnological Enzyme Picture
Figure 2. Global Biotechnological Enzyme Revenue Market Share by Drug Type in 2021
Figure 3. Hydrolases
Figure 4. Lyases
Figure 5. Isomerases
Figure 6. Ligases
Figure 7. Others
Figure 8. Biotechnological Enzyme Revenue Market Share by Application in 2021
Figure 9. Industrial Catalysts Picture
Figure 10. Therapeutic Agents Picture
Figure 11. Analytic Reagents Picture
Figure 12. Others Picture
Figure 13. Global Biotechnological Enzyme Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Biotechnological Enzyme Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Biotechnological Enzyme Revenue Market Share by Region (2017-2028)
Figure 16. Global Biotechnological Enzyme Revenue Market Share by Region in 2021
Figure 17. North America Biotechnological Enzyme Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Biotechnological Enzyme Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Biotechnological Enzyme Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Biotechnological Enzyme Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Biotechnological Enzyme Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Biotechnological Enzyme Market Drivers
Figure 23. Biotechnological Enzyme Market Restraints
Figure 24. Biotechnological Enzyme Market Trends
Figure 25. Novozymes Recent Developments and Future Plans
Figure 26. North Carolina Biotechnology Center Recent Developments and Future Plans
Figure 27. Lumis Biotech Recent Developments and Future Plans
Figure 28. Zytex Recent Developments and Future Plans
Figure 29. AB Enzymes Recent Developments and Future Plans
Figure 30. EPYGEN LABS LLC. Recent Developments and Future Plans
Figure 31. Fermenta Biotech Limited Recent Developments and Future Plans
Figure 32. CPC Biotech Recent Developments and Future Plans
Figure 33. Nfinita Biotech Private Limited Recent Developments and Future Plans
Figure 34. MetGen Recent Developments and Future Plans
Figure 35. SYNKROMAX BIOTECH PVT LTD. Recent Developments and Future Plans
Figure 36. Biocatalysts Ltd. Recent Developments and Future Plans
Figure 37. Henkel AG & Co. Recent Developments and Future Plans
Figure 38. KGaA Recent Developments and Future Plans
Figure 39. Global Biotechnological Enzyme Revenue Share by Players in 2021
Figure 40. Biotechnological Enzyme Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players Biotechnological Enzyme Revenue Market Share in 2021
Figure 42. Global Top 10 Players Biotechnological Enzyme Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global Biotechnological Enzyme Revenue Share by Drug Type in 2021
Figure 45. Global Biotechnological Enzyme Market Share Forecast by Drug Type (2023-2028)
Figure 46. Global Biotechnological Enzyme Revenue Share by Application in 2021
Figure 47. Global Biotechnological Enzyme Market Share Forecast by Application (2023-2028)
Figure 48. North America Biotechnological Enzyme Sales Market Share by Drug Type (2017-2028)
Figure 49. North America Biotechnological Enzyme Sales Market Share by Application (2017-2028)
Figure 50. North America Biotechnological Enzyme Revenue Market Share by Country (2017-2028)
Figure 51. United States Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe Biotechnological Enzyme Sales Market Share by Drug Type (2017-2028)
Figure 55. Europe Biotechnological Enzyme Sales Market Share by Application (2017-2028)
Figure 56. Europe Biotechnological Enzyme Revenue Market Share by Country (2017-2028)
Figure 57. Germany Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Biotechnological Enzyme Sales Market Share by Drug Type (2017-2028)
Figure 63. Asia-Pacific Biotechnological Enzyme Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Biotechnological Enzyme Revenue Market Share by Region (2017-2028)
Figure 65. China Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Biotechnological Enzyme Sales Market Share by Drug Type (2017-2028)
Figure 72. South America Biotechnological Enzyme Sales Market Share by Application (2017-2028)
Figure 73. South America Biotechnological Enzyme Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa Biotechnological Enzyme Sales Market Share by Drug Type (2017-2028)
Figure 77. Middle East and Africa Biotechnological Enzyme Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Biotechnological Enzyme Revenue Market Share by Country (2017-2028)
Figure 79. Turkey Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE Biotechnological Enzyme Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novozymes North Carolina Biotechnology Center Lumis Biotech Zytex AB Enzymes EPYGEN LABS LLC. Fermenta Biotech Limited CPC Biotech Nfinita Biotech Private Limited MetGen SYNKROMAX BIOTECH PVT LTD. Biocatalysts Ltd. Henkel AG & Co. KGaA
Related Reports
Product Tags
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>